Log In
BCIQ
Print this Print this
 

BBT-012

  Manage Alerts
Collapse Summary General Information
Company Bolder BioTechnology Inc.
DescriptionLong-acting interferon (IFN) alpha analog
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today